Photodynamic therapy for cervical precancer (CIN2)
Part of Infections clinical trials.
This study tests a light-based treatment (photodynamic therapy) for cervical precancer called CIN2. It may be an option if you want to avoid surgery and preserve the cervix.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 60 years old.
- You have been diagnosed with moderate cervical precancer (CIN2) by a biopsy within the last 3 months.
- You have not had certain abnormal Pap results or signs of invasive cancer.
- You do not have severe pelvic infection, undiagnosed vaginal bleeding, or active allergies.
- You are not pregnant or breastfeeding, and have not had cervical surgery or certain treatments in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light-activated drug (ALA-PDT) to treat low-grade cervical changes caused by HPV 16 or 18. It may help clear the virus and prevent progression to more serious disease.
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
This study tests a special light-based treatment (called HAL-PDT) for early cervical changes (CIN2) that were found on a recent biopsy. The goal is to see if this treatment can safely remove these changes and prevent them from becoming cancer.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
This study tests a light-activated therapy (HAL-PDT) to treat high-grade cervical dysplasia before considering surgery. It compares the response to standard surgery, aiming to see if the light therapy can help avoid or delay more invasive procedures.
This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.
Hear when a new HPV (Human Papillomavirus)-Associated trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.